Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
Lam LL, Pavlakis N, Shitara K, Sjoquist KM, Martin AJ, Yip S, Kang YK, Bang YJ, Chen LT, Moehler M, Bekaii-Saab T, Alcindor T, O'Callaghan CJ, Tebbutt NC, Hague W, Chan H, Rha SY, Lee KW, Gebski V, Jaworski A, Zalcberg J, Price T, Simes J, Goldstein D. Lam LL, et al. Among authors: rha sy. BMC Cancer. 2023 Feb 22;23(1):180. doi: 10.1186/s12885-023-10642-7. BMC Cancer. 2023. PMID: 36814222 Free PMC article. Clinical Trial.
Predictive Value of the nProfiler 1 Assay for the Efficacy of Adjuvant S-1-Based Doublet Chemotherapy in Stage III Gastric Cancer: A Post-Hoc Analysis of a Randomized Phase III Trial.
Lee DK, Lee CK, Kim HS, Sym SJ, Zang DY, Kim KH, Lim JH, Kim HS, Lee KH, Gee HY, Rha SY, Kim H, Jung M. Lee DK, et al. Among authors: rha sy. Cancer Res Treat. 2024 Nov 12. doi: 10.4143/crt.2024.705. Online ahead of print. Cancer Res Treat. 2024. PMID: 39529388 Free article.
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial.
Park H, Kang DY, Ahn JM, Yun SC, Park KH, Kang SH, Suh J, Bae JW, Park S, Cho JH, Suh JW, Lee BK, Rha SW, Won H, Jang JS, Kim MH, Lee CH, Ahn YK, Oh JH, Bae JS, Park CS, Choi J, Lee JB, Lee SW, Hur SH, Kwon O, Park SJ, Park DW, Tailored-Chip Trial Investigators OBOT. Park H, et al. Among authors: rha sw. EuroIntervention. 2024 Nov 4;20(21):e1355-e1362. doi: 10.4244/EIJ-D-24-00437. EuroIntervention. 2024. PMID: 39492701 Free article. Clinical Trial.
Prognostic Value of Pulmonary Artery Systolic Pressure in Severe Rheumatic Mitral Stenosis.
Choi YJ, Choi JY, Lee J, Choi BG, Park S, Kang DO, Park EJ, Kim JB, Roh SY, Choi CU, Kim JW, Kim EJ, Rha SW, Park CG, Yong HS, Baek MJ, Na JO. Choi YJ, et al. Among authors: rha sw. Circ Cardiovasc Imaging. 2024 Oct;17(10):e016302. doi: 10.1161/CIRCIMAGING.123.016302. Epub 2024 Oct 15. Circ Cardiovasc Imaging. 2024. PMID: 39405388
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer.
Pavlakis N, Shitara K, Sjoquist K, Martin A, Jaworski A, Tebbutt N, Bang YJ, Alcindor T, O'Callaghan C, Strickland A, Rha SY, Lee KW, Kim JS, Bai LY, Hara H, Oh DY, Yip S, Zalcberg J, Price T, Simes J, Goldstein D. Pavlakis N, et al. Among authors: rha sy. J Clin Oncol. 2024 Oct 4:JCO2400055. doi: 10.1200/JCO.24.00055. Online ahead of print. J Clin Oncol. 2024. PMID: 39365958
1,280 results